Page 43 - e-CPG-SLE-8_5_24
P. 43

Management of Systemic Lupus Erythematosus

           receiving IVIG in high dose or by rapid infusion. 81, level III  It has therefore
           been suggested that a slow infusion rate of low concentration of IVIG
           products may reduce the thromboembolic events. 80, level III




























































                                      26
   38   39   40   41   42   43   44   45   46   47   48